1-4 of 4
Erica Hochard, PhD
Close
Sort by
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5760.
https://doi.org/10.1182/blood-2018-99-117654
Published: 2018
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5642.
https://doi.org/10.1182/blood-2018-99-117497
Published: 2018
Journal Articles

Daratumumab Combined with Pomalidomide and Dexamethasone (DPd) for Patients with Relapsed/Refractory Multiple Myeloma in a Single Institution

Al-Ola Abdallah, MD, Joseph P. McGuirk, DO, Leyla Shune, MD, Neil Dunavin, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Siddhartha Ganguly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1856.
https://doi.org/10.1182/blood.V130.Suppl_1.1856.1856
Published: 2017
Journal Articles

Outcomes of Vdpace with Immunomodulator Treatment in Initial and Relapsed/Refractory Multiple Myeloma in a Single Center

Al-Ola Abdallah, MD, Joseph P. McGuirk, DO, Leyla Shune, MD, Erica Hochard, PhD, Neil Dunavin, MD, Zahra Mahmoudjafari, PhD, Siddhartha Ganguly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5422.
https://doi.org/10.1182/blood.V130.Suppl_1.5422.5422
Published: 2017